Options
Project Title
Discovery of a Novel TFEB Regulation Pathway by the c-Abl Kinase Reveals a Common Therapeutic Approach for Sphingolipidosis
Partner Organisations
Internal ID
1190334
Principal Investigator
Silvana Zanlungo
Start Date
2018
Views
18
Last Week
2
2
Last Month
6
6
Acquisition Date
Nov 20, 2024
Nov 20, 2024
6 results
Now showing
1 - 6 of 6
-
Publicationc-Abl Inhibition Activates TFEB and Promotes Cellular Clearance in a Lysosomal Disorder( 2020)
Scopus© Citations 30 8 -
Publicationc-Abl activates RIPK3 signaling in Gaucher disease( 2021)
Scopus© Citations 16 10 -
PublicationProteomic Analysis of Niemann-Pick Type C Hepatocytes Reveals Potential Therapeutic Targets for Liver Damage( 2021)
Scopus© Citations 9 3 -
PublicationA Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids( 2023)
3 -
PublicationIdentification of genetic modifiers of murine hepatic β-glucocerebrosidase activity( 2021)
Scopus© Citations 5 19 -
PublicationComplement Component C3 Participates in Early Stages of Niemann–Pick C Mouse Liver Damage( 2020)
Scopus© Citations 9 5